Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

5.0%

1 terminated out of 20 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed with results

Key Signals

86% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (9)
P 2 (2)

Trial Status

Completed6
Recruiting5
Unknown4
Not Yet Recruiting2
Terminated1
Enrolling By Invitation1

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (20)

Showing 20 of 20 trials
NCT07127718Phase 2RecruitingPrimary

Preventive Strategies for Early and Late Complications of Leptospirosis

NCT07520279Enrolling By Invitation

Xpert® Tropical Fever Test on GeneXpert® Edge X System

NCT07358910Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

NCT04288674RecruitingPrimary

Leptospirosis Registry - LeptoScope

NCT05425524Not ApplicableRecruitingPrimary

Leptospirosis Care Bundle Study

NCT06945822Not ApplicableNot Yet RecruitingPrimary

Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI

NCT06859619Not ApplicableNot Yet Recruiting

Serological Measurement of Montpellier Professionals' Contacts with Infectious Agents Responsible for Animal-borne Diseases

NCT05300425CompletedPrimary

Seroprevalence of Leptospirosis in Val Müstair, Switzerland

NCT04034550Not ApplicableActive Not RecruitingPrimary

Cohort of Hospitalized Patients Suspected of Leptospirosis

NCT05413720Not ApplicableCompletedPrimary

Study of the Innate Immune Response to the Acute Phase of Human Leptospirosis - IMMUNOLEPTO

NCT05436756Not ApplicableRecruitingPrimary

Chronic Post-leptospirosis Manifestations in Reunion

NCT04882046Not ApplicableUnknownPrimary

Study of the Incidence of Jarisch-Herxheimer Reaction in Leptospirosis Patients in New Caledonia

NCT02000635UnknownPrimary

Study of Decreasing Kinetics of the Leptospiremia During Antibiotic Treatment of Leptospirosis in Martinique

NCT03912506CompletedPrimary

Severe Leptospirosis in Non-tropical Areas

NCT03497572CompletedPrimary

Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine

NCT01607047UnknownPrimary

French West Indies Leptospirosis Study

NCT01080989Not ApplicableCompleted

The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon Islands

NCT01766830Not ApplicableCompleted

Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever)

NCT02898519UnknownPrimary

Immune Response After Leptospirosis Infection

NCT00592566Phase 2TerminatedPrimary

Desmopressin and Dexamethasone Adjunctive Treatment for Leptospirosis

Showing all 20 trials

Research Network

Activity Timeline